Diagnostic and Treatment Approaches Involving Transthyretin in Amyloidogenic Diseases
Transthyretin (TTR) is a thyroid hormone-binding protein which transports thyroxine from the bloodstream to the brain. The structural stability of TTR in tetrameric form is crucial for maintaining its original functions in blood or cerebrospinal fluid (CSF). The altered structure of TTR due to genet...
Main Authors: | Gil Yong Park, Angelo Jamerlan, Kyu Hwan Shim, Seong Soo A. An |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/12/2982 |
Similar Items
-
Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism
by: Jin-Beom Si, et al.
Published: (2021-04-01) -
The Structural Understanding of Transthyretin Misfolding and the Inspired Drug Approaches for the Treatment of Heart Failure Associated With Transthyretin Amyloidosis
by: Shan He, et al.
Published: (2021-02-01) -
NON-VAL30MET-TRANSTHYRETIN AMYLOID CARDIOMYOPATHY. LITERATURE REVIEW AND CLINICAL CASE
by: A. Ya. Gudkova, et al.
Published: (2018-03-01) -
Studies of an unusual transthyretin protein (TTR GLU51_SER52DUP) associated with familial amyloidosis
by: Abdullahi, Hassan
Published: (2017) -
Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage
by: Pallavi Manral, et al.
Published: (2015-01-01)